Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Induction of chronic lymphocytic leukemia-like disease in STYK1/NOK transgenic mice

Biochemical and Biophysical Research Communications(2022)10.1016/j.bbrc.2022.08.017Source: DataRank Database

Induction of chronic lymphocytic leukemia-like disease in STYK1/NOK transgenic mice is a research paper published in Biochemical and Biophysical Research Communications (2022). On theSindex it has a DataRank of 0. It has been cited 3 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access3 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)Impact (FWCI 0.41)OA: hybridTopics (33)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (3)

Li Liu ORCID,Haley O. Tucker ORCID,Yin Yang ORCID

Live enrichment

PubMed:35970044 OpenAlex:https://openalex.org/W4290705930

CAMS Innovation Fund for Medical Sciences

Grant: 2017-I2M-3-007

National Institutes of Health

Grant: 01CA31534

National Institute on Alcohol Abuse and Alcoholism

Grant: U01 AA020926

Cancer Prevention and Research Institute of Texas

Grant: RP100612

Cancer Prevention and Research Institute of Texas

Grant: RP120348

National Natural Science Foundation of China

Grant: 81550030

Chinese Academy of Meteorological Sciences

FWCI

0.41

Citation Percentile

0.6%

Citation Trend

2024

2025

hybridLicense: cc-by

journalhttps://doi.org/10.1016/j.bbrc.2022.08.017

publisherhttps://doi.org/10.1016/j.bbrc.2022.08.017

publisherhttps://api.elsevier.com/content/article/PII:S0006291X22011305?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0006291X22011305?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/35970044

Fields of Study

Chronic Lymphocytic Leukemia ResearchGlycosylation and Glycoproteins ResearchImmunodeficiency and Autoimmune Disorders

MeSH Terms

AnimalsHumansMice, TransgenicLeukemia, Lymphocytic, Chronic, B-CellReceptor Protein-Tyrosine KinasesMice

Keywords

CD5Immune systemCD19PhenotypeGenetically modified mouseBiologyChronic lymphocytic leukemiaTransgeneLymphatic systemLymphocyteDiseaseImmunologyCancer researchMedicineLeukemiaPathologyLymphomaGeneGeneticsB lymphocyteCllB1 CellsLymphadenectasisStyk1/nok

Sustainable Development Goals

SDG 0: Good health and well-being